The American Heart Association has awarded the grant to the two prestigious hospitals to create a national center for research on these afflictions. Peripheral artery disease affects 8 to 10 million Americans and over 200 million people across the world, while critical limb ischemia affects 1 to 2 percent of this population. It consists of severely obstructed arteries, causing reduced blood flow to the extremities and painful skin ulcers, and can require limb amputation, especially in patients with diabetes. The treatment and prevention of critical limb ischemia should reduce amputations as well as health-care spending.
Researchers hope to discover the causes of the disease’s progression and “figure out ways to best deliver the most effective care with these therapies with patients with peripheral artery disease and diabetes to prevent the critical limb ischemia from developing,” according to Dr. Mark Creager, director of Dartmouth-Hitchcock’s Heart and Vascular Center.
The New England Council congratulates Brigham & Women’s and Dartmouth-Hitchcock on this grant and wishes them much success in their research. Read more in New Hampshire Union Leader.
Recently from the Blog
Biogen Announces Collaborations to Develop Treatments for Neurological Disorders